Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Yao‐Chun Hsu, Daniel Q. Huang, Mindie H. Nguyen
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 8, pp. 524-537
Closed Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 82
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease
Zobair M. Younossi, Maria Stepanova, Reem Q. Al Shabeeb, et al.
Hepatology Communications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 49
Modeling and analysis of the fractional-order epidemic model to investigate mutual influence in HIV/HCV co-infection
Parvaiz Ahmad Naik, Bijal M. Yeolekar, Sania Qureshi, et al.
Nonlinear Dynamics (2024) Vol. 112, Iss. 13, pp. 11679-11710
Closed Access | Times Cited: 48
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world
Sahith Kudaravalli, Daniel Q. Huang, Ming-Lun Yeh, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 33-41
Closed Access | Times Cited: 20
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung‐Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 12, pp. 834-851
Closed Access | Times Cited: 20
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
Daniel Q. Huang, Joseph Hoang, Rubayet Kamal, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 7, pp. 790-799
Closed Access | Times Cited: 18
Association Between Elevation of Serum Alanine Aminotransferase and HBsAg Seroclearance After Nucleos(t)ide Analog Withdrawal
Ying‐Nan Tsai, Jia‐Ling Wu, Cheng‐Hao Tseng, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access | Times Cited: 4
Development of a sandwich-type electrochemical DNA sensor based on CeO2/AuPt nanoprobes for highly sensitive detection of hepatitis B virus DNA
Jian Mao, Jiaxin Wang, Hongli Chen, et al.
Bioelectrochemistry (2025) Vol. 163, pp. 108901-108901
Closed Access | Times Cited: 1
Global Analysis of a Fractional‐Order Hepatitis B Virus Model Under Immune Response in the Presence of Cytokines
Parvaiz Ahmad Naik, Bijal M. Yeolekar, Sania Qureshi, et al.
Advanced Theory and Simulations (2024) Vol. 7, Iss. 12
Closed Access | Times Cited: 13
Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2019
Jiao Su, Yuanhao Liang, Xiao‐Feng He
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 12
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Xiandi Meng, Ge Zhu, Yong‐Guang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116702-116702
Open Access | Times Cited: 7
Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population‐based cohort study
Yao‐Chun Hsu, Yi‐Hsian Lin, Teng‐Yu Lee, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 4, pp. 463-473
Closed Access | Times Cited: 21
HBV Vaccines: Advances and Development
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 19
Chronic Hepatitis B Infection: New Approaches towards Cure
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 18
Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
Chao Chen, Ling Wei, Wenwen He, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102424-102424
Open Access | Times Cited: 6
Multidimensional Interactive Cascading Nanochips for Detection of Multiple Liver Diseases via Precise Metabolite Profiling
Zhiyu Li, Weili Peng, Juan Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 6
Prevalence of hepatitis B and C viruses among migrant workers in Qatar
Gheyath K. Nasrallah, Hiam Chemaitelly, Ahmed Ismail, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
Dong Li, Yassir Hamadalnil, Thomas Tu
Viruses (2024) Vol. 16, Iss. 9, pp. 1361-1361
Open Access | Times Cited: 6
Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients
Chinmay Bera, Nashla Hamdan‐Pérez, Keyur Patel
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1046-1046
Open Access | Times Cited: 5
An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action
Malihe Naderi, Zahra Salavatiha, Urvashee Gogoi, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
Hui Ma, Qing-Zhu Yan, Jingru Ma, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1295-1312
Open Access | Times Cited: 5
The prognosis and immune repertoire characteristics of HBsAg and anti-HBs double positive chronic hepatitis B patients
Huijun Liang, Haifang Wang, Min-Feng Liang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Hepatitis B vaccine and juvenile idiopathic arthritis: comparison of the seropositivity rates with healthy children at the time of diagnosis and booster dose response under treatment
Merve İşeri Nepesov, Güneş Gür, Rabia Gönül Sezer, et al.
Clinical Rheumatology (2025)
Closed Access
AFB1 consolidates HBV harm to induce liver injury and carcinogenic risk by inactivating FTCD-AS1-PXR-MASP1 axis
Yaqi Xing, Wen Zhong, Xuejun Wu, et al.
Toxicology (2025) Vol. 511, pp. 154057-154057
Closed Access
Factors influencing hepatitis B vaccination intention and behavior among college students in Tibet: Insights from the expanded theory of planned behavior
Chen Qi, Jun Ma, Ruipeng Wu, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top